Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients
Kohne, CH × Cunningham, D Di Costanzo, F Glimelius, B Blijham, G Aranda, E Scheithauer, W Rougier, P Palmer, M Wils, J Baron, B Pignatti, F Schöffski, Patrick Micheel, S Hecker, H #
Kluwer Academic Publishers
Annals of Oncology vol:13 issue:2 pages:308-317
Background: Patients with metastatic colorectal cancer are usually offered systemic chemotherapy as palliative treatment. A multivariate analysis was performed in order to identify predictors and their constellation that allow a valid prediction of the outcome in patients treated with 5-fluorouracil (5-FU)-based therapy.